content: <PAGE>   1
  
  
  
  
                As filed with the Securities and Exchange Commission
                                  on July 19, 1996
  
  
           ======================================================================
                         SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549
  
                                      FORM S-8
  
                            REGISTRATION STATEMENT UNDER
                             THE SECURITIES ACT OF 1933
  
                        IMMULOGIC PHARMACEUTICAL CORPORATION
               (Exact name of registrant as specified in its charter)
  
                      DELAWARE                               13-3397957
           (State or other jurisdiction of                (I.R.S. Employer
            incorporation or organization)               Identification No.)
  
                  610 LINCOLN STREET, WALTHAM, MASSACHUSETTS 02154
                 (Address of Principal Executive Offices) (Zip Code)
  
                          1993 DIRECTOR'S STOCK OPTION PLAN
                              (Full title of the plan)
  
                                  RICHARD N. SMALL
                     VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
                        IMMULOGIC PHARMACEUTICAL CORPORATION
                                 610 LINCOLN STREET
                            WALTHAM, MASSACHUSETTS 02154
                       (Name and address of agent for service)
  
                                     (617) 466-6000
                (Telephone number, including area code, of agent for service)
  
           ======================================================================
                           CALCULATION OF REGISTRATION FEE
  
                                       Proposed   Proposed
           Title of                    maximum    maximum
           securities     Amount       offering   aggregate    Amount of
           to be          to be        price      offering     registration
           registered     registered   per share  price        fee
           ----------     ----------   ---------  ---------    ------------
  
           Common Stock,   100,000     $7.00(1)   $700,000(1)  $242.00
           $.01 par        shares
           value
  
           ----------------------------------------------------------------------
           (1)  Estimated solely for the purpose of calculating the registration
                fee, and based upon the average of the high and low prices of the
                Common Stock on the Nasdaq National Market on July 17, 1996 in
                accordance with Rules 457(c) and 457(h) of the Securities Act of
                1933.
  
           ======================================================================
  
  
  
  
  
  
  
  
  
                                  Page 1 of 9 pages
                            Exhibit Index begins on page 5
  
  
  
  <PAGE>   2
  
  
           Statement of Incorporation by Reference
           ---------------------------------------
  
                This Registration Statement on Form S-8 incorporates by reference
           the contents of the Registration Statement on Form S-8, File No.
           33-89022, relating to the Registrant's 1993 Director's Stock
           Option Plan.
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
                                          -2-
  
  
  
  <PAGE>   3
  
  
                                     SIGNATURES
  
                Pursuant to the requirements of the Securities Act, the Registrant
           certifies that it has reasonable grounds to believe that it meets all
           of the requirements for filing on Form S-8 and has duly caused this
           Registration Statement to be signed on its behalf by the undersigned,
           thereunto duly authorized, in the City of Waltham, Commonwealth of
           Massachusetts on the 18th day of July, 1996.
  
  
                                         IMMULOGIC PHARMACEUTICAL CORPORATION
  
  
  
                                         By: /s/ Robert J. Gerety
                                            ---------------------------------
                                            Robert J. Gerety, M.D., Ph.D.
                                            President and
                                            Chief Executive Officer
  
  
  
                                  POWER OF ATTORNEY
  
                We, the undersigned officers and directors of ImmuLogic
           Pharmaceutical Corporation Inc. hereby severally constitute Robert J.
           Gerety, Richard N. Small and Stacey L. Channing, and each of them
           singly, our true and lawful attorneys with full power to them, and each
           of them singly, to sign for us and in our names in the capacities
           indicated below, the Registration Statement on Form S-8 filed herewith
           and any and all subsequent amendments to said Registration Statement,
           and generally to do all such things in our names and behalf in our
           capacities as officers and directors to enable ImmuLogic Pharmaceutical
           Corporation to comply with all requirements of the Securities and
           Exchange Commission, hereby ratifying and confirming our signatures as
           they may be signed by said attorneys, or any of them, to said
           Registration Statement and any and all amendments thereto.
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
                                          -3-
  
  
  
  <PAGE>   4
  
  
  
  
  
  
  
  
  
                Pursuant to the requirements of the Securities Act, this
           Registration Statement has been signed below by the following persons
           in the capacities and on the date indicated.
  
         Signature                            Title                    Date
         ---------                            -----                    ----
  
  
         /s/ Robert J. Gerety             President, Chief        )
         -----------------------------    Executive Officer       )
         Robert J. Gerety, M.D., Ph.D.    and Director            )
                                          (Principal Executive    )
                                          Officer)                )
                                                                  )
                                                                  )
         /s/ Richard N. Small             Vice President,         )
         -----------------------------    Chief Financial Officer )
         Richard N. Small                 (Principal Financial    )
                                          and Accounting Officer) )
                                                                  )
                                                                  )
         /s/ Malcolm L. Gefter            Director                )
         -----------------------------                            )
         Malcolm L. Gefter, Ph.D.                                 )
                                                                  )
                                                                  )
                                                                  )
                                                                  )
         /s/ Alan J. Dalby                Director                )
         -----------------------------                            )
         Alan J. Dalby                                            )
                                                                  ) July 18, 1996
                                                                  )               
                                                                  )               
                                                                  )               
         /s/ M Howard Jacobson            Director                )
         -----------------------------                            )
         M Howard Jacobson                                        )
                                                                  )
                                                                  )
                                                                  )
                                                                  )
         /s/ Kenneth L. Melmon            Director                )
         -----------------------------                            )
         Kenneth L. Melmon, M.D.                                  )
                                                                  )
                                                                  )
                                                                  )
                                                                  )
         /s/ Larry Soll                   Director                )
         -----------------------------                            )
         Larry Soll, Ph.D.                                        )
                                                                  )
                                                                  )
                                                                  )
                                                                  )
  
  
  
  
  
                                          -4-
  
  
  
  <PAGE>   5
  
  
                                    EXHIBIT INDEX
                                    -------------
   
  
      Exhibit
      Number       Description                                         
      ------       -----------                                         
                                                                       
       4.1 *       By-Laws of the Registrant                           
                                                                       
       4.2 *       Specimen Certificate of Common Stock of             
                   the Registrant                                      
                                                                       
       4.3 **      Rights Agreement, dated as of July 11, 1995,        
                   between the Registrant and the First National       
                   Bank of Boston, as Rights Agent, as amended         
                                                                       
       5           Opinion of Hale and Dorr                            
                                                                       
      23.1         Consent of Hale and Dorr (included in Exhibit 5)    
                                                                       
      23.2         Consent of Coopers & Lybrand L.L.P.                 
                                                                       
      24           Power of Attorney (included in the signature pages  
                   of this Registration Statement)                     
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
           ----------------------
  
           *    Incorporated herein by reference from the Registrant's
                Registration Statement on Form S-1 (File No. 33-39592).
  
           **   Incorporated herein by reference from the Registrant's Current
                Report on Form 8-K dated July 11, 1995.
metadata_documents: [{"type": "S-8", "sequence": "1", "description": "IMMULOGIC PHARM. 1993 DIRECTORS STOCK OPTION PLAN", "secsgml_size_bytes": 10759}]
metadata_filer: {"company-data": {"conformed-name": "IMMULOGIC PHARMACEUTICAL CORP /DE", "cik": "0000873731", "assigned-sic": "2834", "irs-number": "133397957", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-08423", "film-number": "96596682"}, "business-address": {"street1": "610 LINCOLN ST", "city": "WALTHAM", "state": "MA", "zip": "02154", "phone": "6174666000"}, "mail-address": {"street1": "610 LINCOLN ST", "city": "WALTHAM", "state": "MA", "zip": "02154"}}
text: 1
  
                As filed with the Securities and Exchange Commission
                                  on July 19, 1996
  
           ======================================================================
                         SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549
  
                                      FORM S-8
  
                            REGISTRATION STATEMENT UNDER
                             THE SECURITIES ACT OF 1933
  
                        IMMULOGIC PHARMACEUTICAL CORPORATION
               (Exact name of registrant as specified in its charter)
  
                      DELAWARE                               13-3397957
           (State or other jurisdiction of                (I.R.S. Employer
            incorporation or organization)               Identification No.)
  
                  610 LINCOLN STREET, WALTHAM, MASSACHUSETTS 02154
                 (Address of Principal Executive Offices) (Zip Code)
  
                          1993 DIRECTOR'S STOCK OPTION PLAN
                              (Full title of the plan)
  
                                  RICHARD N. SMALL
                     VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
                        IMMULOGIC PHARMACEUTICAL CORPORATION
                                 610 LINCOLN STREET
                            WALTHAM, MASSACHUSETTS 02154
                       (Name and address of agent for service)
  
                                     (617) 466-6000
                (Telephone number, including area code, of agent for service)
  
           ======================================================================
                           CALCULATION OF REGISTRATION FEE
  
                                       Proposed   Proposed
           Title of                    maximum    maximum
           securities     Amount       offering   aggregate    Amount of
           to be          to be        price      offering     registration
           registered     registered   per share  price        fee
           ----------     ----------   ---------  ---------    ------------
  
           Common Stock,   100,000     $7.00(1)   $700,000(1)  $242.00
           $.01 par        shares
           value
  
           ----------------------------------------------------------------------
           (1)  Estimated solely for the purpose of calculating the registration
                fee, and based upon the average of the high and low prices of the
                Common Stock on the Nasdaq National Market on July 17, 1996 in
                accordance with Rules 457(c) and 457(h) of the Securities Act of
                1933.
  
           ======================================================================
  
                                  Page 1 of 9 pages
                            Exhibit Index begins on page 5
  2
  
           Statement of Incorporation by Reference
           ---------------------------------------
  
                This Registration Statement on Form S-8 incorporates by reference
           the contents of the Registration Statement on Form S-8, File No.
           33-89022, relating to the Registrant's 1993 Director's Stock
           Option Plan.
  
                                          -2-
  3
  
                                     SIGNATURES
  
                Pursuant to the requirements of the Securities Act, the Registrant
           certifies that it has reasonable grounds to believe that it meets all
           of the requirements for filing on Form S-8 and has duly caused this
           Registration Statement to be signed on its behalf by the undersigned,
           thereunto duly authorized, in the City of Waltham, Commonwealth of
           Massachusetts on the 18th day of July, 1996.
  
                                         IMMULOGIC PHARMACEUTICAL CORPORATION
  
                                         By: /s/ Robert J. Gerety
                                            ---------------------------------
                                            Robert J. Gerety, M.D., Ph.D.
                                            President and
                                            Chief Executive Officer
  
                                  POWER OF ATTORNEY
  
                We, the undersigned officers and directors of ImmuLogic
           Pharmaceutical Corporation Inc. hereby severally constitute Robert J.
           Gerety, Richard N. Small and Stacey L. Channing, and each of them
           singly, our true and lawful attorneys with full power to them, and each
           of them singly, to sign for us and in our names in the capacities
           indicated below, the Registration Statement on Form S-8 filed herewith
           and any and all subsequent amendments to said Registration Statement,
           and generally to do all such things in our names and behalf in our
           capacities as officers and directors to enable ImmuLogic Pharmaceutical
           Corporation to comply with all requirements of the Securities and
           Exchange Commission, hereby ratifying and confirming our signatures as
           they may be signed by said attorneys, or any of them, to said
           Registration Statement and any and all amendments thereto.
  
                                          -3-
  4
  
                Pursuant to the requirements of the Securities Act, this
           Registration Statement has been signed below by the following persons
           in the capacities and on the date indicated.
  
         Signature                            Title                    Date
         ---------                            -----                    ----
  
         /s/ Robert J. Gerety             President, Chief        )
         -----------------------------    Executive Officer       )
         Robert J. Gerety, M.D., Ph.D.    and Director            )
                                          (Principal Executive    )
                                          Officer)                )
                                                                  )
                                                                  )
         /s/ Richard N. Small             Vice President,         )
         -----------------------------    Chief Financial Officer )
         Richard N. Small                 (Principal Financial    )
                                          and Accounting Officer) )
                                                                  )
                                                                  )
         /s/ Malcolm L. Gefter            Director                )
         -----------------------------                            )
         Malcolm L. Gefter, Ph.D.                                 )
                                                                  )
                                                                  )
                                                                  )
                                                                  )
         /s/ Alan J. Dalby                Director                )
         -----------------------------                            )
         Alan J. Dalby                                            )
                                                                  ) July 18, 1996
                                                                  )               
                                                                  )               
                                                                  )               
         /s/ M Howard Jacobson            Director                )
         -----------------------------                            )
         M Howard Jacobson                                        )
                                                                  )
                                                                  )
                                                                  )
                                                                  )
         /s/ Kenneth L. Melmon            Director                )
         -----------------------------                            )
         Kenneth L. Melmon, M.D.                                  )
                                                                  )
                                                                  )
                                                                  )
                                                                  )
         /s/ Larry Soll                   Director                )
         -----------------------------                            )
         Larry Soll, Ph.D.                                        )
                                                                  )
                                                                  )
                                                                  )
                                                                  )
  
                                          -4-
  5
  
                                    EXHIBIT INDEX
                                    -------------
   
  
      Exhibit
      Number       Description                                         
      ------       -----------                                         
                                                                       
       4.1 *       By-Laws of the Registrant                           
                                                                       
       4.2 *       Specimen Certificate of Common Stock of             
                   the Registrant                                      
                                                                       
       4.3 **      Rights Agreement, dated as of July 11, 1995,        
                   between the Registrant and the First National       
                   Bank of Boston, as Rights Agent, as amended         
                                                                       
       5           Opinion of Hale and Dorr                            
                                                                       
      23.1         Consent of Hale and Dorr (included in Exhibit 5)    
                                                                       
      23.2         Consent of Coopers & Lybrand L.L.P.                 
                                                                       
      24           Power of Attorney (included in the signature pages  
                   of this Registration Statement)                     
  
           ----------------------
  
           *    Incorporated herein by reference from the Registrant's
                Registration Statement on Form S-1 (File No. 33-39592).
  
           **   Incorporated herein by reference from the Registrant's Current
                Report on Form 8-K dated July 11, 1995.